157 related articles for article (PubMed ID: 22910183)
1. MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia.
Clarke M; Dumon S; Ward C; Jäger R; Freeman S; Dawood B; Sheriff L; Lorvellec M; Kralovics R; Frampton J; García P
Leukemia; 2013 Mar; 27(3):661-70. PubMed ID: 22910183
[TBL] [Abstract][Full Text] [Related]
2. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
3. MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
Heinrichs S; Conover LF; Bueso-Ramos CE; Kilpivaara O; Stevenson K; Neuberg D; Loh ML; Wu WS; Rodig SJ; Garcia-Manero G; Kantarjian HM; Look AT
Elife; 2013 Jul; 2():e00825. PubMed ID: 23878725
[TBL] [Abstract][Full Text] [Related]
4. MYBL2 Supports DNA Double Strand Break Repair in Hematopoietic Stem Cells.
Bayley R; Blakemore D; Cancian L; Dumon S; Volpe G; Ward C; Almaghrabi R; Gujar J; Reeve N; Raghavan M; Higgs MR; Stewart GS; Petermann E; García P
Cancer Res; 2018 Oct; 78(20):5767-5779. PubMed ID: 30082276
[TBL] [Abstract][Full Text] [Related]
5. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
[TBL] [Abstract][Full Text] [Related]
6. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
Calvisi DF; Simile MM; Ladu S; Frau M; Evert M; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo F; Pascale RM
Hepatology; 2011 Apr; 53(4):1226-36. PubMed ID: 21480327
[TBL] [Abstract][Full Text] [Related]
7. MYBL2 Is Targeted by miR-143-3p and Regulates Breast Cancer Cell Proliferation and Apoptosis.
Chen J; Chen X
Oncol Res; 2018 Jul; 26(6):913-922. PubMed ID: 29268817
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma.
Le L; Luo J; Wu H; Chen L; Tang X; Fu F
Eur J Histochem; 2021 Mar; 65(2):. PubMed ID: 33782625
[TBL] [Abstract][Full Text] [Related]
9. lncRNA RPSAP52 induced the development of tongue squamous cell carcinomas via miR-423-5p/MYBL2.
Wu X; Gong Z; Ma L; Wang Q
J Cell Mol Med; 2021 May; 25(10):4744-4752. PubMed ID: 33787061
[TBL] [Abstract][Full Text] [Related]
10. MiR-30b-5p inhibits proliferation and promotes apoptosis of medulloblastoma cells via targeting MYB proto-oncogene like 2 (MYBL2).
Xu C; He Z; Lin C; Shen Z
J Investig Med; 2020 Aug; 68(6):1179-1185. PubMed ID: 32690599
[TBL] [Abstract][Full Text] [Related]
11. Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis.
Zhang K; Fu G; Pan G; Li C; Shen L; Hu R; Zhu S; Chen Y; Cui H
Cell Death Dis; 2018 Oct; 9(10):1035. PubMed ID: 30305611
[TBL] [Abstract][Full Text] [Related]
12. circRNA circ-MYBL2 is a novel tumor suppressor and potential biomarker in multiple myeloma.
Yu S; Ai L; Wei W; Pan J
Hum Cell; 2021 Jan; 34(1):219-228. PubMed ID: 33058028
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
[TBL] [Abstract][Full Text] [Related]
14. High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma.
Guan Z; Cheng W; Huang D; Wei A
Curr Res Transl Med; 2018 Mar; 66(1):27-32. PubMed ID: 29274707
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
[TBL] [Abstract][Full Text] [Related]
16. miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4.
Li X; Jiao M; Hu J; Qi M; Zhang J; Zhao M; Liu H; Xiong X; Dong X; Han B
Prostate; 2020 Jun; 80(9):674-686. PubMed ID: 32294305
[TBL] [Abstract][Full Text] [Related]
17. MYBL2, a link between proliferation and differentiation in maturing colon epithelial cells.
Papetti M; Augenlicht LH
J Cell Physiol; 2011 Mar; 226(3):785-91. PubMed ID: 20857481
[TBL] [Abstract][Full Text] [Related]
18. Gadd45a regulates hematopoietic stem cell stress responses in mice.
Chen Y; Ma X; Zhang M; Wang X; Wang C; Wang H; Guo P; Yuan W; Rudolph KL; Zhan Q; Ju Z
Blood; 2014 Feb; 123(6):851-62. PubMed ID: 24371210
[TBL] [Abstract][Full Text] [Related]
19. A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer.
Liu Q; Liu H; Huang X; Fan X; Xiao Z; Yan R; Yao J; An G; Ge Y; Miao J; Liu J
Cancer Gene Ther; 2023 Jan; 30(1):192-208. PubMed ID: 36151333
[TBL] [Abstract][Full Text] [Related]
20. MYBL2 (B-MYB) in cervical cancer: putative biomarker.
Astbury K; McEvoy L; Brian H; Spillane C; Sheils O; Martin C; O'Leary JJ
Int J Gynecol Cancer; 2011 Feb; 21(2):206-12. PubMed ID: 21270603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
